Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival
Open Access
- 9 November 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
With a 5-year survival of ˂ 10%, pancreatic cancer is one of the leading causes of cancer-related deaths. Given the role of the distribution of tumor-infiltrating lymphocyte (TILs) subtypes in the tumor and its microenvironment in predicting prognosis, the development of new targeted therapies based on T-cell adaptive response has gained considerable attention. This study aimed to examine the peritumoral spread of TILs and its relationship with other prognostic parameters and survival. This study included 60 patients with pancreatic cancer who had undergone surgery with follow-up between 2011 and 2021. Demographic characteristics, tumor histopathological features, peritumoral TILs counts, and intratumoral programmed cell death protein-1 (PD-1) and programmed death ligand − 1 (PD-L1) positivity were evaluated. Furthermore, overall survival and their efficacy in predicting survival according to TNM stage were analyzed. The number of cluster differentiation-3 positive (CD3 P) TILs increased with advancing pathological T stage. CD3 P and CD8 P TIL counts were higher in patients with peripancreatic fatty tissue invasion. Patients with PD-L1 positivity and higher TIL counts had better survival rates. PD-L1-negative patients with a low CD8 positive/total lymph node count (P/T) ratio had a longer survival. Moreover, patients with poorly differentiated tumors with low CD3 P/T and CD8 P/T ratios had a longer survival. The CD3 P/T and CD8 P/T ratios were compatible with the automatic and manual measurements. Age, tumor differentiation, N stage, and peritumoral TIL count and subtype, when evaluated together with the presence of PD-L1 in the tumor tissue, may have prognostic significance for survival in patients with pancreatic cancer.Keywords
This publication has 44 references indexed in Scilit:
- Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunityCancer Cell, 2021
- The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectivesClinical Immunology, 2021
- Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic CancerMolecular Therapy-Oncolytics, 2020
- The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysisEuropean Journal of Cancer, 2020
- Immune cell score in pancreatic cancer—comparison of hotspot and whole-section techniquesVirchows Archiv, 2019
- The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysisHepatobiliary & Pancreatic Diseases International, 2018
- Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinomaCurrent Medical Science, 2017
- PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot stainingInternational Journal of Clinical Oncology, 2017
- Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for CancerJournal of the American College of Surgeons, 2015
- The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival After Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011